THE PROPERTIES AND LONGITUDINAL EXPERIENCE OF CHINESE TYPE A BOTULINUM TOXIN FOR THE TREATMENT OF FOCAL DYSTONIA AND HEMIFACIAL SPASM
中国医学科学杂志(英文版)2003年0卷第4期 页码:254-259
Updated:2024-04-10
|
Share with wechat friends or circle of friends
Export references
THE PROPERTIES AND LONGITUDINAL EXPERIENCE OF CHINESE TYPE A BOTULINUM TOXIN FOR THE TREATMENT OF FOCAL DYSTONIA AND HEMIFACIAL SPASM
Affiliations:
1. Wan Xinhua 1,,Tang Xiaofu 1 and Wang Yinchun 2 1 Department of Neurology,PUMC Hospital,CAMS &PUMC,Beijing100730 2 Lanzhou Institute of Biological Products,Lanzhou,730046
2. PUMC Hospital
3. CAMS &PUMC
4. ,China
5. Lanzhou Institute of Biological Products
Author bio:
Funds:
DOI:
中图分类号:R746.9
纸质出版日期:2003
Accepted:
Scan QR Code
THE PROPERTIES AND LONGITUDINAL EXPERIENCE OF CHINESE TYPE A BOTULINUM TOXIN FOR THE TREATMENT OF FOCAL DYSTONIA AND HEMIFACIAL SPASM[J]. 中国医学科学杂志(英文版), 2003,0(4):254-259.
THE PROPERTIES AND LONGITUDINAL EXPERIENCE OF CHINESE TYPE A BOTULINUM TOXIN FOR THE TREATMENT OF FOCAL DYSTONIA AND HEMIFACIAL SPASM[J]. Chinese medical sciences journal, 2003, 0(4): 254-259.
THE PROPERTIES AND LONGITUDINAL EXPERIENCE OF CHINESE TYPE A BOTULINUM TOXIN FOR THE TREATMENT OF FOCAL DYSTONIA AND HEMIFACIAL SPASM[J]. 中国医学科学杂志(英文版), 2003,0(4):254-259.DOI:
THE PROPERTIES AND LONGITUDINAL EXPERIENCE OF CHINESE TYPE A BOTULINUM TOXIN FOR THE TREATMENT OF FOCAL DYSTONIA AND HEMIFACIAL SPASM[J]. Chinese medical sciences journal, 2003, 0(4): 254-259.DOI:
THE PROPERTIES AND LONGITUDINAL EXPERIENCE OF CHINESE TYPE A BOTULINUM TOXIN FOR THE TREATMENT OF FOCAL DYSTONIA AND HEMIFACIAL SPASM
摘要
Abstract
Objective.To introduce the properties of Chinese type A botulinum toxin(CBTXA
made by Lanzhou Institute of Biological Products)
and its long?term effect for focal dystonia and hemifacial spasm.Method.The purity and recovery of crude and crystalline toxin were tested.Long?term data from305patients with hemifacial spasm(HFS)
blepharospasm(BS)and cervical dystonia(CD)were evalu-ated and subgroups of patients received CBTXA injections between1994and2000in at least six sepa-rate treatment sessions
with follow up for2~8years.The therapeutic results of the last session CBTXA injections were analyzed in comparison with the first session.Result.CBTXA purity was high[(2.55~2.60)×10 7 LD50/mgPr
A260/A280≤0.55
high molecular substance accounted for99.2%of total proteins].Long term treatment with CBTXA in patients with focal dystonia and HFS was not associated with any decline in benefit
and efficacy may improve slightly with repeat treatments.CBTXA is an excellent long-term treatment of HFS
BS and CD.Conclusion.We conclude that Chinese type A botulinum toxin is of botulinum toxin therapy quality standard according to results obtained from the basic study and long?term clinical applications.The re?injection of CBTXA significantly improves the quality of life of most patients and is a safe
effective and comparatively economical treatment for patients with focal dystonia and HFS.